CCNYSEChemicals & Allied ProductsFiscal year ends December 31
Chemours Co
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$12.62−0.12 (-0.94%)
Close on Oct 19, 2026
- Market cap
- $1.91B
- P/E (TTM)
- –
- Dividend yield
- 4.06%
Chemours statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Chemicals & Allied Products companies for comparison
Valuation
| Measure | Chemours | Industry median |
|---|---|---|
| Market Cap | $1.90B | $197.05M |
| Enterprise Value | $5.10B | $106.56M |
| PS Ratio | 0.33 | 3.93 |
| P/FCF Ratio | 8.71 | 18.25 |
| P/OCF Ratio | 4.78 | 13.78 |
Enterprise value
| Measure | Chemours | Industry median |
|---|---|---|
| EV / Sales | 0.88 | 2.69 |
| EV / EBITDA | 9.43 | 14.86 |
| EV / FCF | 23.40 | 21.02 |
Income (trailing twelve months)
| Measure | Chemours | Industry median |
|---|---|---|
| Revenue | $5.80B | $57.94M |
| Gross Profit | $887.00M | $90.47M |
| Pretax Income | -$52.00M | -$14.45M |
| Net Income | -$304.00M | -$22.46M |
| EBITDA | $541.00M | -$16.91M |
| EPS (Diluted) | -$2.00 | -$0.83 |
Margins
| Measure | Chemours | Industry median |
|---|---|---|
| Gross Margin | 15.3% | 52.3% |
| Pretax Margin | -0.90% | -13.0% |
| Profit Margin | -5.24% | -39.2% |
| EBITDA Margin | 9.33% | -31.3% |
| FCF Margin | 3.76% | -8.85% |
Returns
| Measure | Chemours | Industry median |
|---|---|---|
| Return on Equity (ROE) | -339.7% | -53.1% |
| Return on Assets (ROA) | -4.16% | -41.0% |
Growth
| Measure | Chemours | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -0.92% | 6.01% |
| Revenue Growth (3Y CAGR) | -5.26% | 2.25% |
| Revenue Growth (5Y CAGR) | 3.17% | 6.42% |
Balance sheet
| Measure | Chemours | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $671.00M | $62.42M |
| Total Debt | $3.87B | $120.13M |
| Net Cash (Debt) | -$3.20B | $15.68M |
| Net Cash Per Share | -$21.27 | $0.65 |
| Equity (Book Value) | -$49.00M | $48.79M |
| Book Value Per Share | -$0.33 | $1.36 |
| Tangible Book Value | -$95.00M | $23.06M |
| Working Capital | $1.23B | $75.77M |
Financial position
| Measure | Chemours | Industry median |
|---|---|---|
| Current Ratio | 1.66 | 3.30 |
| Quick Ratio | 0.78 | 2.39 |
| Debt / EBITDA | 7.16 | 3.35 |
| Debt / FCF | 17.76 | 5.05 |
| Net Debt / EBITDA | 5.92 | 2.22 |
Cash flow (trailing twelve months)
| Measure | Chemours | Industry median |
|---|---|---|
| Operating Cash Flow | $397.00M | -$12.35M |
| Capital Expenditures | -$179.00M | -$1.06M |
| Free Cash Flow | $218.00M | -$20.28M |
| FCF Per Share | $1.45 | -$0.41 |
Efficiency
| Measure | Chemours | Industry median |
|---|---|---|
| Asset Turnover | 0.79 | 0.38 |
| Inventory Turnover | 3.26 | 2.67 |
| Revenue Per Employee | $1.02M | $398.96K |
| Profits Per Employee | -$53.33K | -$732.08K |
| Employee Count | 5,700 | 73 |
Dividends and yields
| Measure | Chemours | Industry median |
|---|---|---|
| Earnings Yield | -16.0% | -21.2% |
| FCF Yield | 11.5% | -7.64% |
| Dividend Yield | 4.06% | 1.83% |
| Shareholder Yield | 4.06% | 0.00% |
| Dividend Per Share | $0.51 | $0.83 |
| Dividend Growth (YoY) | -48.8% | 2.37% |
| Years of Dividend Growth | 0 | 0 |
| FCF Payout Ratio | 24.8% | 51.6% |
Shares
| Measure | Chemours | Industry median |
|---|---|---|
| Shares Outstanding | 150,499,000 | 59,128,900 |
| Shares Change (YoY) | 0.51% | 11.1% |
| Shares Change (QoQ) | 0.07% | 0.54% |
| Float | 149,057,000 | 48,744,500 |
| Shares Held by Insiders | 0.96% | 11.8% |
| Shares Held by Institutions | 90.2% | 59.4% |
Taxes
| Measure | Chemours | Industry median |
|---|---|---|
| Income Tax | $253.00M | $91.50K |
Scores
| Measure | Chemours | Industry median |
|---|---|---|
| Altman Z-Score | 1.35 | 0.10 |
| Piotroski F-Score | 4 | 4 |
| Beneish M-Score | -2.90 | -2.62 |
Calculated by StockData from Chemours's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.